Cargando…
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA
The SARS-CoV-2 Delta variant rose to dominance in mid-2021, likely propelled by an estimated 40%–80% increased transmissibility over Alpha. To investigate if this ostensible difference in transmissibility is uniform across populations, we partner with public health programs from all six states in Ne...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913280/ https://www.ncbi.nlm.nih.gov/pubmed/35480627 http://dx.doi.org/10.1016/j.xcrm.2022.100583 |
_version_ | 1784667400705146880 |
---|---|
author | Earnest, Rebecca Uddin, Rockib Matluk, Nicholas Renzette, Nicholas Turbett, Sarah E. Siddle, Katherine J. Loreth, Christine Adams, Gordon Tomkins-Tinch, Christopher H. Petrone, Mary E. Rothman, Jessica E. Breban, Mallery I. Koch, Robert Tobias Billig, Kendall Fauver, Joseph R. Vogels, Chantal B.F. Bilguvar, Kaya De Kumar, Bony Landry, Marie L. Peaper, David R. Kelly, Kevin Omerza, Greg Grieser, Heather Meak, Sim Martha, John Dewey, Hannah B. Kales, Susan Berenzy, Daniel Carpenter-Azevedo, Kristin King, Ewa Huard, Richard C. Novitsky, Vlad Howison, Mark Darpolor, Josephine Manne, Akarsh Kantor, Rami Smole, Sandra C. Brown, Catherine M. Fink, Timelia Lang, Andrew S. Gallagher, Glen R. Pitzer, Virginia E. Sabeti, Pardis C. Gabriel, Stacey MacInnis, Bronwyn L. Tewhey, Ryan Adams, Mark D. Park, Daniel J. Lemieux, Jacob E. Grubaugh, Nathan D. |
author_facet | Earnest, Rebecca Uddin, Rockib Matluk, Nicholas Renzette, Nicholas Turbett, Sarah E. Siddle, Katherine J. Loreth, Christine Adams, Gordon Tomkins-Tinch, Christopher H. Petrone, Mary E. Rothman, Jessica E. Breban, Mallery I. Koch, Robert Tobias Billig, Kendall Fauver, Joseph R. Vogels, Chantal B.F. Bilguvar, Kaya De Kumar, Bony Landry, Marie L. Peaper, David R. Kelly, Kevin Omerza, Greg Grieser, Heather Meak, Sim Martha, John Dewey, Hannah B. Kales, Susan Berenzy, Daniel Carpenter-Azevedo, Kristin King, Ewa Huard, Richard C. Novitsky, Vlad Howison, Mark Darpolor, Josephine Manne, Akarsh Kantor, Rami Smole, Sandra C. Brown, Catherine M. Fink, Timelia Lang, Andrew S. Gallagher, Glen R. Pitzer, Virginia E. Sabeti, Pardis C. Gabriel, Stacey MacInnis, Bronwyn L. Tewhey, Ryan Adams, Mark D. Park, Daniel J. Lemieux, Jacob E. Grubaugh, Nathan D. |
author_sort | Earnest, Rebecca |
collection | PubMed |
description | The SARS-CoV-2 Delta variant rose to dominance in mid-2021, likely propelled by an estimated 40%–80% increased transmissibility over Alpha. To investigate if this ostensible difference in transmissibility is uniform across populations, we partner with public health programs from all six states in New England in the United States. We compare logistic growth rates during each variant’s respective emergence period, finding that Delta emerged 1.37–2.63 times faster than Alpha (range across states). We compute variant-specific effective reproductive numbers, estimating that Delta is 63%–167% more transmissible than Alpha (range across states). Finally, we estimate that Delta infections generate on average 6.2 (95% CI 3.1–10.9) times more viral RNA copies per milliliter than Alpha infections during their respective emergence. Overall, our evidence suggests that Delta’s enhanced transmissibility can be attributed to its innate ability to increase infectiousness, but its epidemiological dynamics may vary depending on underlying population attributes and sequencing data availability. |
format | Online Article Text |
id | pubmed-8913280 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-89132802022-03-11 Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA Earnest, Rebecca Uddin, Rockib Matluk, Nicholas Renzette, Nicholas Turbett, Sarah E. Siddle, Katherine J. Loreth, Christine Adams, Gordon Tomkins-Tinch, Christopher H. Petrone, Mary E. Rothman, Jessica E. Breban, Mallery I. Koch, Robert Tobias Billig, Kendall Fauver, Joseph R. Vogels, Chantal B.F. Bilguvar, Kaya De Kumar, Bony Landry, Marie L. Peaper, David R. Kelly, Kevin Omerza, Greg Grieser, Heather Meak, Sim Martha, John Dewey, Hannah B. Kales, Susan Berenzy, Daniel Carpenter-Azevedo, Kristin King, Ewa Huard, Richard C. Novitsky, Vlad Howison, Mark Darpolor, Josephine Manne, Akarsh Kantor, Rami Smole, Sandra C. Brown, Catherine M. Fink, Timelia Lang, Andrew S. Gallagher, Glen R. Pitzer, Virginia E. Sabeti, Pardis C. Gabriel, Stacey MacInnis, Bronwyn L. Tewhey, Ryan Adams, Mark D. Park, Daniel J. Lemieux, Jacob E. Grubaugh, Nathan D. Cell Rep Med Article The SARS-CoV-2 Delta variant rose to dominance in mid-2021, likely propelled by an estimated 40%–80% increased transmissibility over Alpha. To investigate if this ostensible difference in transmissibility is uniform across populations, we partner with public health programs from all six states in New England in the United States. We compare logistic growth rates during each variant’s respective emergence period, finding that Delta emerged 1.37–2.63 times faster than Alpha (range across states). We compute variant-specific effective reproductive numbers, estimating that Delta is 63%–167% more transmissible than Alpha (range across states). Finally, we estimate that Delta infections generate on average 6.2 (95% CI 3.1–10.9) times more viral RNA copies per milliliter than Alpha infections during their respective emergence. Overall, our evidence suggests that Delta’s enhanced transmissibility can be attributed to its innate ability to increase infectiousness, but its epidemiological dynamics may vary depending on underlying population attributes and sequencing data availability. Elsevier 2022-03-11 /pmc/articles/PMC8913280/ /pubmed/35480627 http://dx.doi.org/10.1016/j.xcrm.2022.100583 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Earnest, Rebecca Uddin, Rockib Matluk, Nicholas Renzette, Nicholas Turbett, Sarah E. Siddle, Katherine J. Loreth, Christine Adams, Gordon Tomkins-Tinch, Christopher H. Petrone, Mary E. Rothman, Jessica E. Breban, Mallery I. Koch, Robert Tobias Billig, Kendall Fauver, Joseph R. Vogels, Chantal B.F. Bilguvar, Kaya De Kumar, Bony Landry, Marie L. Peaper, David R. Kelly, Kevin Omerza, Greg Grieser, Heather Meak, Sim Martha, John Dewey, Hannah B. Kales, Susan Berenzy, Daniel Carpenter-Azevedo, Kristin King, Ewa Huard, Richard C. Novitsky, Vlad Howison, Mark Darpolor, Josephine Manne, Akarsh Kantor, Rami Smole, Sandra C. Brown, Catherine M. Fink, Timelia Lang, Andrew S. Gallagher, Glen R. Pitzer, Virginia E. Sabeti, Pardis C. Gabriel, Stacey MacInnis, Bronwyn L. Tewhey, Ryan Adams, Mark D. Park, Daniel J. Lemieux, Jacob E. Grubaugh, Nathan D. Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA |
title | Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA |
title_full | Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA |
title_fullStr | Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA |
title_full_unstemmed | Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA |
title_short | Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA |
title_sort | comparative transmissibility of sars-cov-2 variants delta and alpha in new england, usa |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913280/ https://www.ncbi.nlm.nih.gov/pubmed/35480627 http://dx.doi.org/10.1016/j.xcrm.2022.100583 |
work_keys_str_mv | AT earnestrebecca comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT uddinrockib comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT matluknicholas comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT renzettenicholas comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT turbettsarahe comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT siddlekatherinej comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT lorethchristine comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT adamsgordon comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT tomkinstinchchristopherh comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT petronemarye comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT rothmanjessicae comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT brebanmalleryi comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT kochroberttobias comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT billigkendall comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT fauverjosephr comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT vogelschantalbf comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT bilguvarkaya comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT dekumarbony comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT landrymariel comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT peaperdavidr comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT kellykevin comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT omerzagreg comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT grieserheather comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT meaksim comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT marthajohn comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT deweyhannahb comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT kalessusan comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT berenzydaniel comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT carpenterazevedokristin comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT kingewa comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT huardrichardc comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT novitskyvlad comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT howisonmark comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT darpolorjosephine comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT manneakarsh comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT kantorrami comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT smolesandrac comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT browncatherinem comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT finktimelia comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT langandrews comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT gallagherglenr comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT pitzervirginiae comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT sabetipardisc comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT gabrielstacey comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT macinnisbronwynl comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT tewheyryan comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT adamsmarkd comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT parkdanielj comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT lemieuxjacobe comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa AT grubaughnathand comparativetransmissibilityofsarscov2variantsdeltaandalphainnewenglandusa |